Divis Laboratories Ltd share price logo

Divis Laboratories Ltd (DIVISLAB)

₹4479.71.86%

bell
Get free price alerts. Set up your Free investment account to get Live Prices.
Overview
Fundamentals
Q3 '23 Results
Technicals
News and Events

Insights on Divis Laboratories Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 3 quarters, 348.0 Cr → 538.0 Cr (in ₹), with an average increase of 18.1% per quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 13.72% to 14.28% in Mar 2024 quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 1.95K Cr → 2.38K Cr (in ₹), with an average increase of 18.1% per quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, DIVISLAB stock has moved up by 13.6%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 126.6% return, outperforming this stock by 118.6%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 51.92% of holdings in Mar 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Zydus Lifesciences Ltd has given 94.7% return, outperforming this stock by 67.4%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 11.33% to 11.19% in Mar 2024 quarter

  • imgNEGATIVE IMPACT

    FII Holding Down

    img

    Foreign Institutions have decreased holdings from 14.86% to 14.68% in Mar 2024 quarter

Performance

  • Day's Low

    Day's High

    ₹4,466
    ₹4,581.3
  • 52 Week's Low

    52 Week's High

    ₹3,295.3
    ₹4,627.95
1 Month Return+ 13.64 %
3 Month Return+ 32.41 %
1 Year Return+ 27.33 %
Previous Close₹4,564.50
Open₹4,565.00
Volume2.23L
Upper Circuit-
Lower Circuit-
Market Cap₹1,21,173.13Cr

Analyst Rating

based on 27 analysts

HOLD
22.22%
Buy
33.33%
Hold
44.44%
Sell

Based on 27 analysts offering long term price targets for Divis Laboratories Ltd. An average target of ₹3871.33

Source: S&P Global Market Intelligence

Company Information

Divis Laboratories Ltd is a leading Indian pharmaceutical company incorporated in 1990. The company specializes in the manufacture of active pharmaceutical ingredients (APIs) and intermediates for the global pharmaceutical market. Divis Laboratories Ltd operates in three lines of business, APIs, Intermediates, and Contract Research and Manufacturing Services (CRAMS).

Divis Laboratories Ltd's top products include APIs and intermediates for anti-infectives, cardiovascular, central nervous system, anti-diabetics, gastro-intestinal and anti-inflammatory treatments. The company is also a leader in the manufacture of custom synthesis and process development services for the global pharmaceutical industry.

Divis Laboratories Ltd is the proud owner of several popular brands, including Divis Life, Divis Pharma and Divis Health. Divis Life offers a range of health and wellness products, while Divis Pharma provides a wide range of APIs, intermediates and custom synthesis services.

Share Price: ₹4479.70 per share as on 19 Jun, 2024 04:01 PM
Market Capitalisation: ₹1,21,173.13Cr as of today
Revenue: ₹2,303.00Cr as on March 2024 (Q1 24)
Net Profit: ₹538.00Cr as on March 2024 (Q1 24)
Listing date: 12 Mar, 2003
Chairperson Name: Ramesh B V Nimmagadda
OrganisationDivis Laboratories Ltd
HeadquartersHyderabad
IndustryPharmaceuticals
E-voting on sharesClick here to vote

Key events for Divis Laboratories Ltd

  • Divis Labs Surpasses Historical Peak, Potential for Further Gains - 11 Jun, 2024

    Divis Laboratories Ltd has surpassed its historical peak, indicating potential for further gains. Technical analysis recommends taking a long position within the price range of Rs 4,485 to Rs 4,550 with a target set at Rs 5,000 and a stop-loss placed at Rs 4,275.

  • Divis Laboratories Positioned for Potential Further Gains - 10 Jun, 2024

    Divis Laboratories has surpassed its previous peak and is positioned for potential further gains. Technical analysis supports a bullish outlook with a target of Rs 5,000 and stop-loss at Rs 4,260.

  • Divis Labs Share Price Expected to Rise - 31 May, 2024

    Divis Laboratories' Q4FY24 performance exceeded expectations, leading analysts to anticipate a near-term increase with shares expected to reach Rs. 4,630 apiece. Insiders owning the majority of the company's shares also stand to benefit from recent gains.

  • Divis Labs Stock Shows Bullish Momentum - 30 May, 2024

    Technical analysis suggests a long position in Divis Laboratories Ltd within the price range of Rs 4,375 to Rs 4,465 with a target of Rs 5,000 and stop-loss at Rs 4,100. The stock has surpassed its historical peak and sustained its price above this range.

  • Divis Labs Hits 52-Week High After Strong Q4 Results - 28 May, 2024

    Divis Laboratories' Q4FY24 results show an 18% YoY growth in consolidated revenue and a 67.6% rise in net profit. A research report upgrades the company's EPS estimates and target price, but downgrades the stock to HOLD.

  • Divis Labs Reports Strong Q4 Results; Analysts Upgrade Ratings - 27 May, 2024

    Divis Laboratories reports consolidated net profit of Rs 538 crore for Q4 FY24, up 67.6% YoY, while revenue rises 18.04%. Prabhudas Lilladher upgrades stock to Accumulate, InCred upgrades to Add.

  • Divis Labs Reports Strong Q4 Earnings and Target Price Upgrade - 26 May, 2024

    Divis Laboratories reports a 67.6% YoY increase in Q4 net profit to Rs 538 crore, beating estimates, and recommends a final dividend of Rs 30 per share. Motilal Oswal raises the company's target price to Rs 3,900 following the earnings beat but retains its Neutral rating on the stock.

  • Divis Labs Reports Strong Q4 Earnings - 25 May, 2024

    Indian pharma major Divis Laboratories reported a consolidated net profit of Rs 538 crore for the Jan-Mar quarter of FY24, marking a 68% increase from the same period last year. The company also announced a final dividend of Rs 30 per share for the financial year 2023-24. For the full fiscal, it reported consolidated revenue from operations increased to Rs 7,845 crore while net profit declined to Rs 1,600 crore.

  • Divis Labs Expected to Post Strong Q4FY24 Results - 24 May, 2024

    Divis Laboratories is expected to report strong Q4FY24 results with significant growth in revenue, EBITDA, and net profit. The company's stock has been performing well, gaining 8.45% in the last month.

  • Underutilization of CDMO Capacity at Divis Labs; Founder's Daughter Buys Properties - 23 May, 2024

    Divis Laboratories' huge CDMO capacity remains underutilized due to a lack of orders. Meanwhile, the founder's daughter has purchased two properties in Hyderabad's posh Jubilee Hills for Rs 80 crore.

  • Divis Labs Likely to Be Excluded From Nifty50 Index - 17 May, 2024

    According to analysts at Nuvama Alternative and Quantitative Research, Divis Laboratories is expected to be replaced by Bharat Electronics Ltd. and Trent Ltd. in the benchmark Nifty50 index during the upcoming reshuffle in September this year, leading to an outflow of $213 million.

Divis Laboratories Ltd Valuation

Divis Laboratories Ltd in the last 5 years

  • Overview

  • Trends

Lowest (28.97x)

November 21, 2022

Industry (65.24x)

June 18, 2024

Today (75.73x)

June 18, 2024

Highest (78.53x)

December 28, 2023

LowHigh

Mutual Fund Holdings

Funds Holdings
SBI Equity Hybrid Fund Direct GrowthSBI Equity Hybrid Fund Direct Growth4.28%
SBI Focused Equity Fund Direct Plan GrowthSBI Focused Equity Fund Direct Plan Growth4.5%
SBI Bluechip Fund Direct GrowthSBI Bluechip Fund Direct Growth2.55%
Axis ELSS Tax Saver Fund Direct Plan Growth OptionAxis ELSS Tax Saver Fund Direct Plan Growth Option3.21%
SBI Multicap Fund Direct GrowthSBI Multicap Fund Direct Growth3.55%

Shareholding Pattern

InvestorsHoldings %Prev. 1 periods3M change
Promoter Holdings
51.92%
0.00
Foreign Institutions
14.68%
0.00
Mutual Funds
14.28%
0.00
Retail Investors
11.19%
0.00
Others
7.93%
0.00

News

Divi's Laboratories Stocks Live Updates: Divi's Laboratories Closes at Rs 4588.6 with 2.49% Weekly Return

Discover the Divi's Laboratories Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track o... Read more

18 Jun, 2024 08:30 AM

Mid-day Mood | Sensex, Nifty hold firm in green after hitting new all-time highs

Maruti Suzuki India, UltraTech Cement, Dr Reddys Laboratories, Divis Laboratories, SBI Life Insurance were the top losers on Nifty.

18 Jun, 2024 12:31 PM

Divi's Laboratories Stocks Live Updates: Divi's Laboratories Closes at Rs 4564.5 with Below-Average Trading Volume

Discover the Divi's Laboratories Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track o... Read more

19 Jun, 2024 08:32 AM
View More

Frequently Asked Questions

  • Get a PAN card.
  • Open a Demat account.
  • Open a Trading account.
  • Link your Demat account to your Trading account.
  • Fund your Trading account.
  • Place an order to buy Divis Laboratories Ltd shares.

Divis Laboratories Ltd (DIVISLAB) share price today is ₹4479.7

Divis Laboratories Ltd is listed on NSE

Divis Laboratories Ltd is listed on BSE

  • Today’s highest price of Divis Laboratories Ltd is ₹4581.3.
  • Today’s lowest price of Divis Laboratories Ltd is ₹4466.

PE Ratio of Divis Laboratories Ltd is 75.73

PE ratio = Divis Laboratories Ltd Market price per share / Divis Laboratories Ltd Earnings per share

Today’s traded volume of Divis Laboratories Ltd(DIVISLAB) is 2.23L.

Today’s market capitalisation of Divis Laboratories Ltd(DIVISLAB) is ₹121173.13Cr.

Divis Laboratories Ltd(DIVISLABPrice
52 Week High
₹4627.95
52 Week Low
₹3295.3

Divis Laboratories Ltd(DIVISLAB) share price is ₹4479.7. It is down -3.20% from its 52 Week High price of ₹4627.95

Divis Laboratories Ltd(DIVISLAB) share price is ₹4479.7. It is up 35.94% from its 52 Week Low price of ₹3295.3

Divis Laboratories Ltd(DIVISLABReturns
1 Day Returns
-84.8%
1 Month Returns
13.64%
3 Month Returns
32.41%
1 Year Returns
27.33%